Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATNM
Stock Latest News
Ratings
Actinium Pharmaceuticals: Promising Advancements in Radiopharmaceutical Pipeline Drive Buy Rating
1d ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Promising Pipeline and Strong Financials Drive Buy Rating
2d ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals’ ATNM-400 Shows Promise in Prostate Cancer Treatment, Earning Buy Rating
13d ago
ATNM
Premium
The Fly
Actinium Pharmaceuticals’ ATNM-400 shows improved survival in prostate cancer
13d ago
ATNM
Premium
Ratings
Promising Preclinical Results for ATNM-400 Drive Buy Rating for Actinium Pharmaceuticals
2M ago
ATNM
Premium
Ratings
Positive Outlook on Actinium Pharmaceuticals: Promising Preclinical Data and Strong Financial Position Drive Buy Rating
2M ago
ATNM
Premium
The Fly
Actinium highlights expanded data set for ATNM-400 in prostate cancer
2M ago
ATNM
Premium
Market News
ATNM Lawsuit Alert! Class Action Lawsuit Against Actinium Pharmaceuticals
3M ago
ATNM
Premium
Ratings
Promising Advancements and Strategic Collaborations Justify Buy Rating for Actinium Pharmaceuticals
3M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Promising Pipeline and Strategic Partnerships Drive Buy Rating
3M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Strong Buy Rating Driven by Promising Pipeline and Stable Financial Position
3M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Innovative Clinical Trials and Promising Preclinical Data Drive Buy Rating
3M ago
ATNM
Premium
The Fly
Actinium enrolls first patient on the trial studying Iomab-ACT
3M ago
ATNM
Premium
Ratings
Promising Preclinical Data and Strong Financial Position Support Buy Rating for Actinium Pharmaceuticals
4M ago
ATNM
Premium
Ratings
Positive Buy Rating for Actinium Pharmaceuticals Driven by Promising Preclinical Data and Strategic Collaborations
4M ago
ATNM
Premium
The Fly
Actinium Pharmaceuticals’ ATNM-400 shows efficacy in prostate cancer study
4M ago
NVS
ATNM
Premium
The Fly
Actinium’s Actimab-A shows antileukemic activity in AML models
4M ago
ATNM
SNDX
Premium
Class Action
Levi & Korsinsky LLP Notifies Shareholders of Actinium Pharmaceuticals, Inc.(ATNM) of a Class Action Lawsuit and an Upcoming Deadline
4M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Strong Financial Health and Promising Clinical Progress Drive Buy Rating
4M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Strategic Advancements and Financial Stability Signal Undervalued Opportunity
5M ago
ATNM
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
PTN
SNY
Premium
The Fly
Actinium announces positive ATNM-400 results in prostate cancer
5M ago
ATNM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
